Cancer fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal cell carcinoma (ChRCC) and those that are present are indifferent to the ...

Scientists have developed a new molecule that can deliver powerful immune-activating treatment directly to cancer cells, ...

The story of monoclonal antibodies is a testament to the transformative power of scientific innovation combined with strategic business decisions. Monoclonal antibodies (mAbs) are lab-made proteins ...

Trained immunity in alveolar macrophages can lead to damaging lung inflammation, confirming the importance of context in this phenomenon.

Scientists tracked how human immune cells attack pig kidneys after transplant—and found a way to fight back using precision ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Scientists have revealed how certain immune cells may be quietly helping prostate cancer grow—and how blocking them could help the body fight back.

The study found that when adjusting for variables like age, race, and underlying health conditions, women had a 31% higher ...

Engineered chip mimics bone marrow and immune system, offering a faster, tailored path for cancer immunotherapy.

In healthy adults, a single low dose of IMP761 continues to be safe and appears to reduce the activity of T-cells, a clinical ...

At first glance, some people seem to have recovered from COVID-19. They no longer test positive and can return to work or ...

Initial meeting of Scientific Advisory Board (SAB) convened to discuss the first-in-human phase 1a/1b clinical trial of ...